KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

Opko Health (OPK) Short-term Investments (2016 - 2018)

Opko Health's Short-term Investments history spans 5 years, with the latest figure at $26.3 million for Q4 2018.

For Q4 2018, Short-term Investments changed N/A year-over-year to $26.3 million; the TTM value through Dec 2018 reached $26.3 million, changed N/A, while the annual FY2018 figure was $26.3 million, N/A changed from the prior year.
Short-term Investments reached $26.3 million in Q4 2018 per OPK's latest filing, up from $15.6 million in the prior quarter.
In the past five years, Short-term Investments ranged from a high of $26.3 million in Q4 2018 to a low of $15.6 million in Q2 2016.